| 1211 | | Plants and parts of plants (including seeds and fruits), of a kind used primarily in perfumery, in pharmacy or for insec- ticidal, fungicidal or similar purposes, fresh or dried, whether ornot cut, crushed or powdered: | | | | |
| 1212 | | Locust beans, seaweeds and other algae, sugar beet and sugar cane, fresh, chilled, frozen or dried, whether or not ground; fruit stones and kernels and other vegetable products (including unroasted chicory roots of the variety Cichorium intybus sativum) of a kind used primarily for human consumption, not elsewhere specified or included: | | | | |
| 1401 | | Vegetable materials of a kind used primarily for plaiting (for example, bamboos, rattans, reeds, rushes, osier, raffia, cleaned, bleached or dyed cereal straw, and lime bark): | | | | |
| 1404.90.10 | 00 | Vegetable hair Vegetable materials of a kind used primarily in brooms or in brushes (for example, broomcorn piassava, couch grass and istle), whether or not in hanks or bundles: | kg | 0.5￠/kg | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,MA,MX, P,SG) | 2.2￠/kg |
| 1404.90.90 | 20 | Raw vegetable materials of a kind used primarily in dyeing or tanning: | | | | |
| 1404.90.90 | 20 | Canaigre, chestnut, curupay, divi-divi, eucalyptus, gall nuts, hemlock, larch, mangrove, myrobalan, oak, quebracho, sumac, tara, urunday, valonia, wattle and other materials of a kind used primarily in tanning | kg | | | |
| 2933.99.55 | | Drugs primarily affecting the central nervous system: | | | | |
| 2936 | | Provitamins and vitamins, natural or reproduced by synthesis (including natural concentrates), derivatives thereof used primarily as vitamins, and intermixtures of the foregoing, whether or not in any solvent: | | | | |
| 2937 | | Hormones, prostaglandins, thromboxanes and leukotrienes, natural or reproduced by synthesis; derivatives and structural analogues thereof, including chain modified polypeptides, used primarily as hormones: | | | | |
| 3004.40.00 | 60 | Medicaments primarily affecting the eyes, ears or respiratory system | kg | | | |
| 3004.40.00 | 20 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 65 | Preparations primarily affecting the electrolytic, caloric or water balance: | | | | |
| 3004.90.91 | 22 | Medicaments primarily affecting the central nervous system: | | | | |
| 3004.90.91 | 50 | Medicaments primarily affecting the digestive system: | | | | |
| 3901 | | Polymers of ethylene, in primary forms: | | | | |
| 3902 | | Polymers of propylene or of other olefins, in primary forms: | | | | |
| 3903 | | Polymers of styrene, in primary forms: | | | | |
| 3904 | | Polymers of vinyl chloride or of other halogenated olefins, in primary forms: | | | | |
| 3905 | | Polymers of vinyl acetate or of other vinyl esters, in primary forms; other vinyl polymers in primary forms: | | | | |
| 3906 | | Acrylic polymers in primary forms: | | | | |
| 3907 | | Polyacetals, other polyethers and epoxide resins, in primary forms; polycarbonates, alkyd resins, polyallyl esters and other polyesters, in primary forms: | | | | |
| 3908 | | Polyamides in primary forms: | | | | |
| 3909 | | Amino-resins, phenolic resins and polyurethanes, in primary forms: | | | | |
| 3910.00.00 | 00 | Silicones in primary forms | kg | 3% | Free (A,AU,BH, CA,CL,E,IL,J,JO, K,MA,MX, P,SG) | 25% |
| 3911 | | Petroleum resins, coumarone-indene resins, polyterpenes, polysulfides, polysulfones and other products specified in note 3 to this chapter, not elsewhere specified or included, in primary forms: | | | | |
